AdBiotics

AdBiotics is a biotechnology company specializing in the discovery and development of novel microbial and phage therapies for various medical applications. They focus on harnessing the power of beneficial microorganisms, or probiotics, to combat and prevent diseases by modulating the human microbiome. Their team of experienced scientists and industry professionals is dedicated to creating innovative and cutting-edge solutions for a range of healthcare challenges, including antibiotic-resistant infections and chronic conditions like obesity and diabetes. AdBiotics believes that a deep understanding of the microbiome and its associated biological processes is key to revolutionizing the field of healthcare and improving patient outcomes. In addition to their core research and development activities, AdBiotics is committed to advancing global health by collaborating with various academic institutions and industry partners. Through these collaborations, they aim to accelerate scientific discovery, optimize the efficiency of their development processes, and ultimately bring life-saving products to market. AdBiotics' mission is to improve human health and well-being by creating novel therapeutics that harness the power of the microbiome. By leveraging the latest advances in genomic, metagenomic, and systems biology, the company is well-positioned to achieve its objectives and make a lasting impact on the future of healthcare.